The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1408
January 21, 2013
View Complete Issue         Table of Contents 2019 
FDA Requires Lower Dosing of Zolpidem
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
FDA Requires Lower Dosing of Zolpidem
January 21, 2013 (Issue: 1408)
On January 10, 2013, the FDA issued a news release to announce that it was requiring the manufacturers of the zolpidem-containing products Ambien, Ambien CR, Edluar and Zolpimist, which are all approved for treatment of insomnia, to lower the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: FDA Requires Lower Dosing of Zolpidem
Article code: 1408a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.